Translational Research GRICS-CineCardiac
Launched by INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, FRANCE · Mar 10, 2025
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • candidate to cardiac MR exam because of ischemic or dilated cardiopathy
- • legally an adult
- • having heath insurance
- • having signed the consent form
- Exclusion Criteria:
- • dyspnea
- • atrial fibrillation
- • pain while lying on the back for a long time
- • inability to follow a procedure
- • contraindication to MRI
- • contraindication to gadolinium chelate injection
About Institut National De La Santé Et De La Recherche Médicale, France
The Institut National de la Santé et de la Recherche Médicale (INSERM) is France's key public research organization dedicated to advancing knowledge in health and biomedical sciences. Established to foster innovation and improve public health outcomes, INSERM conducts a wide range of clinical trials and research initiatives aimed at translating scientific discoveries into effective medical treatments and interventions. With a focus on collaboration among researchers, healthcare professionals, and industry partners, INSERM plays a pivotal role in shaping health policies and enhancing the quality of care in France and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vandoeuvre Lès Nancy, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported